Header Logo

Connection

Kevin Brown to Male

This is a "connection" page, showing publications Kevin Brown has written about Male.
Connection Strength

0.419
  1. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res. 2012 Nov; 25(6):815-8.
    View in: PubMed
    Score: 0.034
  2. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011 Nov 13; 480(7375):99-103.
    View in: PubMed
    Score: 0.032
  3. Developing youth capacity for community-based research: the Sarasota County demonstration project. J Public Health Manag Pract. 2001 Mar; 7(2):53-60.
    View in: PubMed
    Score: 0.015
  4. Youth and tattoos: what school health personnel should know. J Sch Health. 2000 Nov; 70(9):355-60.
    View in: PubMed
    Score: 0.015
  5. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma. Melanoma Res. 2019 10; 29(5):483-490.
    View in: PubMed
    Score: 0.014
  6. Sex specific associations in genome wide association analysis of renal cell carcinoma. Eur J Hum Genet. 2019 10; 27(10):1589-1598.
    View in: PubMed
    Score: 0.014
  7. The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study. PLoS Med. 2019 01; 16(1):e1002724.
    View in: PubMed
    Score: 0.013
  8. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma. Hum Mol Genet. 2018 12 01; 27(23):4145-4156.
    View in: PubMed
    Score: 0.013
  9. Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies. J Invest Dermatol. 2018 12; 138(12):2617-2624.
    View in: PubMed
    Score: 0.013
  10. Analysis of NRAS gain in 657 patients with melanoma and evaluation of its sensitivity to a MEK inhibitor. Eur J Cancer. 2018 01; 89:90-101.
    View in: PubMed
    Score: 0.012
  11. Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Nat Commun. 2017 06 09; 8:15724.
    View in: PubMed
    Score: 0.012
  12. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun. 2017 05 02; 8:15034.
    View in: PubMed
    Score: 0.012
  13. Germline TERT promoter mutations are rare in familial melanoma. Fam Cancer. 2016 Jan; 15(1):139-44.
    View in: PubMed
    Score: 0.011
  14. Urinary organic anion excretion in response to dietary acid and base loading. J Am Soc Nephrol. 1995 Feb; 5(8):1624-9.
    View in: PubMed
    Score: 0.010
  15. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma. J Natl Cancer Inst. 2015 Feb; 107(2).
    View in: PubMed
    Score: 0.010
  16. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Clin Genet. 2015 Sep; 88(3):267-72.
    View in: PubMed
    Score: 0.010
  17. Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2014 Nov 01; 307(9):F1052-62.
    View in: PubMed
    Score: 0.010
  18. The volatile anesthetic isoflurane increases endothelial adenosine generation via microparticle ecto-5'-nucleotidase (CD73) release. PLoS One. 2014; 9(6):e99950.
    View in: PubMed
    Score: 0.010
  19. Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury. Kidney Int. 2014 Apr; 85(4):807-23.
    View in: PubMed
    Score: 0.009
  20. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS One. 2013; 8(8):e72144.
    View in: PubMed
    Score: 0.009
  21. IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI. J Am Soc Nephrol. 2013 Oct; 24(10):1558-70.
    View in: PubMed
    Score: 0.009
  22. The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury. Kidney Int. 2013 Jul; 84(1):90-103.
    View in: PubMed
    Score: 0.009
  23. Paneth cell-mediated multiorgan dysfunction after acute kidney injury. J Immunol. 2012 Dec 01; 189(11):5421-33.
    View in: PubMed
    Score: 0.009
  24. Interleukin-11 protects against renal ischemia and reperfusion injury. Am J Physiol Renal Physiol. 2012 Oct 15; 303(8):F1216-24.
    View in: PubMed
    Score: 0.008
  25. A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am J Physiol Renal Physiol. 2012 Sep; 303(5):F721-32.
    View in: PubMed
    Score: 0.008
  26. Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. Kidney Int. 2012 Oct; 82(8):878-91.
    View in: PubMed
    Score: 0.008
  27. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS One. 2012; 7(2):e30398.
    View in: PubMed
    Score: 0.008
  28. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2012 Feb; 23(2):266-80.
    View in: PubMed
    Score: 0.008
  29. Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology. 2011 May; 53(5):1662-75.
    View in: PubMed
    Score: 0.008
  30. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest. 2011 Jan; 91(1):63-84.
    View in: PubMed
    Score: 0.007
  31. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest. 2010 Aug; 90(8):1209-24.
    View in: PubMed
    Score: 0.007
  32. Human heat shock protein 27 overexpressing mice are protected against hepatic ischemia and reperfusion injury. Transplantation. 2009 May 27; 87(10):1478-87.
    View in: PubMed
    Score: 0.007
  33. Should all patients with duodenal adenocarcinoma be considered for aggressive surgical resection? Am J Surg. 2007 Mar; 193(3):319-24; discussion 324-5.
    View in: PubMed
    Score: 0.006
  34. Gene expression correlates of neurofibrillary tangles in Alzheimer's disease. Neurobiol Aging. 2006 Oct; 27(10):1359-71.
    View in: PubMed
    Score: 0.005
  35. Sarcoidosis: social predictors of severity at presentation. Eur Respir J. 2004 Oct; 24(4):601-8.
    View in: PubMed
    Score: 0.005
  36. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004 Apr; 45(4):1247-58.
    View in: PubMed
    Score: 0.005
  37. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Cancer Res. 2002 May 01; 62(9):2654-9.
    View in: PubMed
    Score: 0.004
  38. No missense mutation of WKL1 in a subgroup of probands with schizophrenia. Mol Psychiatry. 2002; 7(4):419-23.
    View in: PubMed
    Score: 0.004
  39. Severe autosomal recessive rippling muscle disease. Muscle Nerve. 2001 Nov; 24(11):1542-7.
    View in: PubMed
    Score: 0.004
  40. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001 Jan 30; 103(4):485-90.
    View in: PubMed
    Score: 0.004
  41. A cholesterol-lowering diet does not produce adverse psychological effects in children: three-year results from the dietary intervention study in children. Health Psychol. 1999 Nov; 18(6):604-13.
    View in: PubMed
    Score: 0.004
  42. Maternal acceptability of a dietary intervention designed to lower children's intake of saturated fat and cholesterol: the Dietary Intervention Study in Children (DISC). J Am Diet Assoc. 1998 Jan; 98(1):31-4.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.